1. 009 Predicting infection risk in multiple sclerosis patients treated with ocrelizumab: a retrospective cohort study. (23rd August 2021) Authors: Seery, Nabil; Sharmin, Sifat; Li, Vivien; Nguyen, Ai-Lan; Meaton, Claire; Atvars, Roberts; Taylor, Nicola; Tunnell, Kelsey; Carey, Joh; Marriott, Mark P; Buzzard, Katherine A; Ross, Izanne; Dwyer, Chris; Baker, Josephine; Taylor, Lisa; Springs, Kymble; Kilpatrick, Trevor J; Kalincik, Tomas; Monif... Journal: BMJ neurology open Issue: Volume 3(2021) Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increasing incidence and prevalence of multiple sclerosis in the Greater Hobart cohort of Tasmania, Australia. Issue 7 (16th May 2022) Authors: Simpson-Yap, Steve; Atvars, Roberts; Blizzard, Leigh; van der Mei, Ingrid; Taylor, Bruce V Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 7(2022) Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗